Minimal residual disease detected by multiparameter flow cytometry is complementary to genetics for risk stratification treatment in acute myeloid leukemia with biallelic CEBPA mutations.

Saved in:
Bibliographic Details
Title: Minimal residual disease detected by multiparameter flow cytometry is complementary to genetics for risk stratification treatment in acute myeloid leukemia with biallelic CEBPA mutations.
Authors: Deng, Dao-Xing1 (AUTHOR), Zhu, Hong-Hu1 (AUTHOR), Liu, Yan-Rong1 (AUTHOR), Chang, Ying-Jun1 (AUTHOR), Ruan, Guo-Rui1 (AUTHOR), Jia, Jin-Song1 (AUTHOR), Jiang, Hao1 (AUTHOR), Jiang, Qian1 (AUTHOR), Zhao, Xiao-Su1 (AUTHOR), Huang, Xiao-Jun1,2 (AUTHOR) huangxiaojun@bjmu.edu.cn
Source: Leukemia & Lymphoma. Sep2019, Vol. 60 Issue 9, p2181-2189. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2019.1576868